SECsense Logo

Hepion Pharmaceuticals 8-K Report: Key Financial Insights for Investors

$HEPA
Form 8-K
Filed on: 2025-01-15
Source
Hepion Pharmaceuticals 8-K Report: Key Financial Insights for Investors

Based on the provided section of the financial report, here are the key insights:

  1. Entity Identification:
  • Company Name: Hepion Pharmaceuticals, Inc.
  • CIK Number: 0001583771
  • State of Incorporation: Delaware (DE)
  • SEC Filings Registration Number: 001-36856
  • Tax Identification Number: 46-2783806
  1. Address and Contact Information:
  • Address: 399 Thornall Street, First Floor, Edison, NJ 08837
  • Phone Number: (732) 902-4000
  1. Filing Type:
  • Type of Filing: 8-K
  • Filing Date: January 14, 2025
  1. Stock Information:
  • Common Stock Par Value: $0.0001 per share
  • Ticker Symbol: HEPA
  • Exchange: NASDAQ
  1. Reporting Period:
  • Period Ended: January 14, 2025
  1. Units of Measure:
  • Currency: USD (United States Dollar)
  • Shares: Reporting includes a measure indicating shares as a unit.

Insights:

  • The report pertains to Hepion Pharmaceuticals, indicating it is actively reporting financial information as required by SEC regulations.
  • The 8-K filing suggests that the company is disclosing significant events or changes that could impact its financial standing or operations.
  • The stock information indicates that Hepion Pharmaceuticals is publicly traded, which may be relevant for investors and analysts monitoring its performance on NASDAQ.

This summary provides a concise overview of the essential aspects of the financial report, useful for stakeholders or parties interested in the company’s financial disclosures.